• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国到2035年的癌症发病率和死亡率预测。

Cancer incidence and mortality projections in the UK until 2035.

作者信息

Smittenaar C R, Petersen K A, Stewart K, Moitt N

机构信息

Analysis & Evaluation, Cancer Research UK, The Angel Building, 407 St John Street, London EC1V 4AD, UK.

出版信息

Br J Cancer. 2016 Oct 25;115(9):1147-1155. doi: 10.1038/bjc.2016.304. Epub 2016 Oct 11.

DOI:10.1038/bjc.2016.304
PMID:27727232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5117795/
Abstract

BACKGROUND

Cancer incidence and mortality projections are important for understanding the evolving landscape for cancer risk factors as well as anticipating future burden on the health service.

METHODS

We used an age-period-cohort model with natural cubic splines to estimate cancer cases and deaths from 2015 to 2035 based on 1979-2014 UK data. This was converted to rates using ONS population projections. Modified data sets were generated for breast and prostate cancers.

RESULTS

Cancer incidence rates are projected to decrease by 0.03% in males and increase by 0.11% in females yearly between 2015 and 2035; thyroid, liver, oral and kidney cancer are among the fastest accelerating cancers. 243 690 female and 270 261 male cancer cases are projected for 2035. Breast and prostate cancers are projected to be the most common cancers among females and males, respectively in 2035. Most cancers' mortality rate is decreasing; there are notable increases for liver, oral and anal cancer. For 2035, there are 95 961 female deaths projected and 116 585 male deaths projected.

CONCLUSIONS

These findings stress the need to continue efforts to address cancer risk factors. Furthermore, the increased burden of the number of cancer cases and deaths as a result of the growing and ageing population should be taken into consideration by healthcare planners.

摘要

背景

癌症发病率和死亡率预测对于理解癌症风险因素的演变态势以及预测未来卫生服务负担至关重要。

方法

我们使用带有自然三次样条的年龄-时期-队列模型,基于1979 - 2014年英国数据估计2015年至2035年的癌症病例数和死亡数。利用英国国家统计局的人口预测数据将其转换为发病率。针对乳腺癌和前列腺癌生成了修正数据集。

结果

预计2015年至2035年间男性癌症发病率每年下降0.03%,女性每年上升0.11%;甲状腺癌、肝癌、口腔癌和肾癌是增速最快的癌症类型。预计2035年女性癌症病例数为243690例,男性为270261例。预计2035年乳腺癌和前列腺癌将分别成为女性和男性中最常见的癌症。大多数癌症的死亡率在下降;肝癌、口腔癌和肛门癌的死亡率有显著上升。预计2035年女性死亡95961例,男性死亡116585例。

结论

这些发现强调了继续努力应对癌症风险因素的必要性。此外,医疗规划者应考虑到人口增长和老龄化导致的癌症病例数和死亡数负担增加的情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552f/5117795/bc209082d098/bjc2016304f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552f/5117795/edcec942c7c2/bjc2016304f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552f/5117795/5784102cf164/bjc2016304f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552f/5117795/ab865ea1ac65/bjc2016304f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552f/5117795/bc209082d098/bjc2016304f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552f/5117795/edcec942c7c2/bjc2016304f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552f/5117795/5784102cf164/bjc2016304f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552f/5117795/ab865ea1ac65/bjc2016304f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552f/5117795/bc209082d098/bjc2016304f4.jpg

相似文献

1
Cancer incidence and mortality projections in the UK until 2035.英国到2035年的癌症发病率和死亡率预测。
Br J Cancer. 2016 Oct 25;115(9):1147-1155. doi: 10.1038/bjc.2016.304. Epub 2016 Oct 11.
2
Years of potential life lost caused by prostate cancer deaths in the United States-Projection from 2004 through 2050.美国因前列腺癌死亡导致的潜在寿命损失年数-2004 年至 2050 年预测。
Cancer Epidemiol. 2010 Aug;34(4):368-72. doi: 10.1016/j.canep.2010.04.015. Epub 2010 May 26.
3
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
4
Projection of burden of cancer mortality for India, 2011-2026.2011 - 2026年印度癌症死亡负担预测。
Asian Pac J Cancer Prev. 2013;14(7):4387-92.
5
Projected estimates of cancer in Canada in 2024.2024 年加拿大癌症预估。
CMAJ. 2024 May 12;196(18):E615-E623. doi: 10.1503/cmaj.240095.
6
Cancer incidence and mortality: trends in the United Kingdom and constituent countries, 1993 to 2004.癌症发病率与死亡率:1993年至2004年英国及各成员国趋势
Health Stat Q. 2008 Summer(38):33-46.
7
Cancer mortality in the United Kingdom: projections to the year 2025.英国的癌症死亡率:到2025年的预测
Br J Cancer. 2008 Nov 4;99(9):1549-54. doi: 10.1038/sj.bjc.6604710. Epub 2008 Oct 14.
8
Cancer incidence and mortality in Mongolia - National Registry Data.蒙古的癌症发病率和死亡率——国家登记数据
Asian Pac J Cancer Prev. 2010;11(6):1509-14.
9
Patterns of cancer incidence among the population of Qatar: a worldwide comparative study.卡塔尔人群中的癌症发病率模式:一项全球比较研究。
Asian Pac J Cancer Prev. 2008 Jan-Mar;9(1):19-24.
10
Trends in UK regional cancer mortality 1991-2007.1991 - 2007年英国地区癌症死亡率趋势
Br J Cancer. 2016 Feb 2;114(3):340-7. doi: 10.1038/bjc.2015.428. Epub 2016 Jan 14.

引用本文的文献

1
Cross-tissue transcriptome-wide analysis reveals novel insights into thyroid cancer etiology.跨组织全转录组分析揭示了甲状腺癌病因学的新见解。
Discov Oncol. 2025 Jul 17;16(1):1359. doi: 10.1007/s12672-025-03194-8.
2
Process evaluation for the STAMINA randomised controlled trial: A protocol.STAMINA随机对照试验的过程评估:方案
PLoS One. 2025 Jul 14;20(7):e0323275. doi: 10.1371/journal.pone.0323275. eCollection 2025.
3
An assessment of study characteristics, quality and reporting in cancer prehabilitation literature: a scoping review.

本文引用的文献

1
Overdiagnosis and screening for thyroid cancer in Korea.韩国甲状腺癌的过度诊断与筛查
Lancet. 2014 Nov 22;384(9957):1848. doi: 10.1016/S0140-6736(14)62242-X. Epub 2014 Nov 21.
2
Cancer incidence, survival and mortality: explaining the concepts.癌症发病率、生存率和死亡率:解释相关概念。
Int J Cancer. 2014 Oct 15;135(8):1774-82. doi: 10.1002/ijc.28990. Epub 2014 Jun 19.
3
Comment on 'cancer incidence in the United Kingdom: projections to the year 2030'.关于《英国癌症发病率:到2030年的预测》的评论
癌症术前康复文献的研究特征、质量及报告情况评估:一项范围综述
BMJ Open. 2025 Jul 11;15(7):e093832. doi: 10.1136/bmjopen-2024-093832.
4
Landscape of metabolic alterations and treatment strategies in breast cancer.乳腺癌的代谢改变及治疗策略概况
Genes Dis. 2025 Jan 8;12(5):101521. doi: 10.1016/j.gendis.2025.101521. eCollection 2025 Sep.
5
The effect of a 12-session community exercise programme on health measures across varying cancer types and rehabilitation stages.一项为期12节的社区锻炼计划对不同癌症类型和康复阶段的健康指标的影响。
Support Care Cancer. 2025 Jun 20;33(7):603. doi: 10.1007/s00520-025-09609-0.
6
Editorial: Breast cancer imaging: clinical translation of novel methods.社论:乳腺癌成像:新方法的临床转化
Front Oncol. 2025 Mar 20;15:1581169. doi: 10.3389/fonc.2025.1581169. eCollection 2025.
7
Perceived changes in health behaviours and body weight in response to a cancer diagnosis among individuals living with and beyond breast, prostate, and colorectal cancer in the UK: a cross-sectional study.英国乳腺癌、前列腺癌和结直肠癌患者及康复者对癌症诊断的健康行为和体重感知变化:一项横断面研究
Support Care Cancer. 2025 Mar 4;33(3):247. doi: 10.1007/s00520-025-09305-z.
8
Health inequalities in hepatocellular carcinoma surveillance, diagnosis, treatment, and survival in the United Kingdom: a scoping review.英国肝细胞癌监测、诊断、治疗及生存方面的健康不平等:一项范围综述
BJC Rep. 2025 Mar 3;3(1):13. doi: 10.1038/s44276-025-00126-5.
9
Potential biomarkers for predicting the risk of thyroid cancer in immunosenescence: a population-based and externally validated multi omics study.免疫衰老中预测甲状腺癌风险的潜在生物标志物:一项基于人群的外部验证多组学研究
Front Oncol. 2025 Jan 21;14:1525767. doi: 10.3389/fonc.2024.1525767. eCollection 2024.
10
Explainable Thyroid Cancer Diagnosis Through Two-Level Machine Learning Optimization with an Improved Naked Mole-Rat Algorithm.通过使用改进的裸鼹鼠算法进行两级机器学习优化实现可解释的甲状腺癌诊断
Cancers (Basel). 2024 Dec 10;16(24):4128. doi: 10.3390/cancers16244128.
Br J Cancer. 2013 Mar 19;108(5):1213-4. doi: 10.1038/bjc.2013.71. Epub 2013 Feb 21.
4
16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010.2010 年英国归因于生活方式和环境因素的癌症比例。
Br J Cancer. 2011 Dec 6;105 Suppl 2(Suppl 2):S77-81. doi: 10.1038/bjc.2011.489.
5
Cancer incidence in the United Kingdom: projections to the year 2030.英国癌症发病率:预测至 2030 年。
Br J Cancer. 2011 Nov 22;105(11):1795-803. doi: 10.1038/bjc.2011.430. Epub 2011 Oct 27.
6
Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease.是否应使用死亡证明上的死因来评估癌症特异性生存率?一项针对远处转移期疾病患者的研究。
Cancer Invest. 2010 Aug;28(7):758-64. doi: 10.3109/07357901003630959.
7
Overdiagnosis in cancer.癌症过度诊断。
J Natl Cancer Inst. 2010 May 5;102(9):605-13. doi: 10.1093/jnci/djq099. Epub 2010 Apr 22.
8
Predicting the impact of the screening programme for colorectal cancer in the UK.预测英国结直肠癌筛查计划的影响。
J Med Screen. 2008;15(4):163-74. doi: 10.1258/jms.2008.008024.
9
Cancer mortality in the United Kingdom: projections to the year 2025.英国的癌症死亡率:到2025年的预测
Br J Cancer. 2008 Nov 4;99(9):1549-54. doi: 10.1038/sj.bjc.6604710. Epub 2008 Oct 14.
10
Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival.在估计筛查检测对癌症生存的影响时校正领先时间和长度偏倚。
Am J Epidemiol. 2008 Jul 1;168(1):98-104. doi: 10.1093/aje/kwn120. Epub 2008 May 25.